DHPA has filed comments in response to CMS’s CY 2018 Updates to the Quality Payment Program (“QPP”) Proposed Rule. In its comment letter, DHPA provided three specific suggestions for CMS to consider incorporating into the Final Rule to ensure Medicare beneficiaries’ continued access to critically important drug treatments and to facilitate greater participation by independent […]
High-quality, integrated care delivered in the independent medical practice setting is worthy of protection as an alternative to care that is often more costly when furnished in the hospital setting. Read more...
Integrated models of care allow for better coordination across specialties, translating into higher quality, lower cost and more accessible care for patients. Read more...
Recent data, including 2009-2013 Medicare data relating to the cost and utilization of anatomic pathology (AP) services, demonstrates that the GAO report fails to tell the full story about cost and utilization. Read more...
The Digestive Health Physicians Association strongly supports the Removing Barriers to Colorectal Cancer Screening Act (H.R. 1017, S. 479), bipartisan legislation to remove financial barriers to life-saving colorectal cancer screenings and treatment for Medicare beneficiaries. The legislation, introduced by Congressmen Dent (R-PA-15), Payne (D-NJ-10) and Lance (R-NJ-7) as well as Senators Brown (D-OH), Wicker (R-MS), […]
Learn why Medicare patients will continue to face unfair fees for colonoscopies unless Congress passes the Removing Barriers to Colorectal Cancer Screening Act.
U.S. Senator Debbie Stabenow (D-MI) visited DHPA member, Huron Gastroenterology, and met with the group’s physicians regarding healthcare issues being debated in the U.S. Congress. DHPA Board member, Dr. Naresh Gunaratnam, who also serves as research director at Huron Gastro, and his colleagues discussed with Sen. Stabenow the importance of preserving the high quality, cost […]
DHPA joined 268 other leading physician organizations in sending a letter to the Secretary of the U.S. Department of Health and Human Services, Dr. Thomas E. Price, regarding recent policy recommendations that, if implemented, could jeopardize seniors’ access to physician-administered drugs under Medicare Part B, force community clinics to close, and increase costs for seniors. […]